Scolaris Content Display Scolaris Content Display

Study flow diagram.

Figuras y tablas -
Figure 1

Study flow diagram.

Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.

Figuras y tablas -
Figure 2

Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.

Risk of bias summary: review authors' judgements about each risk of bias item from each study

Figuras y tablas -
Figure 3

Risk of bias summary: review authors' judgements about each risk of bias item from each study

Funnel plot of comparison: 2 Organisational interventions versus usual care, outcome: 2.1 Mean systolic blood pressure.

Figuras y tablas -
Figure 4

Funnel plot of comparison: 2 Organisational interventions versus usual care, outcome: 2.1 Mean systolic blood pressure.

Funnel plot of comparison: 2 Organisational interventions versus usual care, outcome: 2.2 Mean diastolic blood pressure.

Figuras y tablas -
Figure 5

Funnel plot of comparison: 2 Organisational interventions versus usual care, outcome: 2.2 Mean diastolic blood pressure.

Funnel plot of comparison: 2 Organisational interventions versus usual care, outcome: 2.3 Blood pressure target achievement.

Figuras y tablas -
Figure 6

Funnel plot of comparison: 2 Organisational interventions versus usual care, outcome: 2.3 Blood pressure target achievement.

Comparison 1: Educational or behavioural interventions for patients versus usual care, Outcome 1: Mean systolic blood pressure

Figuras y tablas -
Analysis 1.1

Comparison 1: Educational or behavioural interventions for patients versus usual care, Outcome 1: Mean systolic blood pressure

Comparison 1: Educational or behavioural interventions for patients versus usual care, Outcome 2: Mean diastolic blood pressure

Figuras y tablas -
Analysis 1.2

Comparison 1: Educational or behavioural interventions for patients versus usual care, Outcome 2: Mean diastolic blood pressure

Comparison 1: Educational or behavioural interventions for patients versus usual care, Outcome 3: Blood pressure target achievement

Figuras y tablas -
Analysis 1.3

Comparison 1: Educational or behavioural interventions for patients versus usual care, Outcome 3: Blood pressure target achievement

Comparison 1: Educational or behavioural interventions for patients versus usual care, Outcome 4: Mean total cholesterol

Figuras y tablas -
Analysis 1.4

Comparison 1: Educational or behavioural interventions for patients versus usual care, Outcome 4: Mean total cholesterol

Comparison 1: Educational or behavioural interventions for patients versus usual care, Outcome 5: Total cholesterol target achievement

Figuras y tablas -
Analysis 1.5

Comparison 1: Educational or behavioural interventions for patients versus usual care, Outcome 5: Total cholesterol target achievement

Comparison 1: Educational or behavioural interventions for patients versus usual care, Outcome 6: Mean low density lipoprotein

Figuras y tablas -
Analysis 1.6

Comparison 1: Educational or behavioural interventions for patients versus usual care, Outcome 6: Mean low density lipoprotein

Comparison 1: Educational or behavioural interventions for patients versus usual care, Outcome 7: Mean high density lipoprotein

Figuras y tablas -
Analysis 1.7

Comparison 1: Educational or behavioural interventions for patients versus usual care, Outcome 7: Mean high density lipoprotein

Comparison 1: Educational or behavioural interventions for patients versus usual care, Outcome 8: Mean triglycerides

Figuras y tablas -
Analysis 1.8

Comparison 1: Educational or behavioural interventions for patients versus usual care, Outcome 8: Mean triglycerides

Comparison 1: Educational or behavioural interventions for patients versus usual care, Outcome 9: Mean HbA1c

Figuras y tablas -
Analysis 1.9

Comparison 1: Educational or behavioural interventions for patients versus usual care, Outcome 9: Mean HbA1c

Comparison 1: Educational or behavioural interventions for patients versus usual care, Outcome 10: HbA1C target achievement

Figuras y tablas -
Analysis 1.10

Comparison 1: Educational or behavioural interventions for patients versus usual care, Outcome 10: HbA1C target achievement

Comparison 1: Educational or behavioural interventions for patients versus usual care, Outcome 11: Mean BMI

Figuras y tablas -
Analysis 1.11

Comparison 1: Educational or behavioural interventions for patients versus usual care, Outcome 11: Mean BMI

Comparison 1: Educational or behavioural interventions for patients versus usual care, Outcome 12: Proporation of participants with secondary stroke

Figuras y tablas -
Analysis 1.12

Comparison 1: Educational or behavioural interventions for patients versus usual care, Outcome 12: Proporation of participants with secondary stroke

Comparison 1: Educational or behavioural interventions for patients versus usual care, Outcome 13: Number of secondary TIAs

Figuras y tablas -
Analysis 1.13

Comparison 1: Educational or behavioural interventions for patients versus usual care, Outcome 13: Number of secondary TIAs

Comparison 1: Educational or behavioural interventions for patients versus usual care, Outcome 14: Number of myocardial infarctions

Figuras y tablas -
Analysis 1.14

Comparison 1: Educational or behavioural interventions for patients versus usual care, Outcome 14: Number of myocardial infarctions

Comparison 1: Educational or behavioural interventions for patients versus usual care, Outcome 15: Number of cardiovascular deaths

Figuras y tablas -
Analysis 1.15

Comparison 1: Educational or behavioural interventions for patients versus usual care, Outcome 15: Number of cardiovascular deaths

Comparison 2: Organisational interventions versus usual care, Outcome 1: Mean systolic blood pressure

Figuras y tablas -
Analysis 2.1

Comparison 2: Organisational interventions versus usual care, Outcome 1: Mean systolic blood pressure

Comparison 2: Organisational interventions versus usual care, Outcome 2: Mean diastolic blood pressure

Figuras y tablas -
Analysis 2.2

Comparison 2: Organisational interventions versus usual care, Outcome 2: Mean diastolic blood pressure

Comparison 2: Organisational interventions versus usual care, Outcome 3: Blood pressure target achievement

Figuras y tablas -
Analysis 2.3

Comparison 2: Organisational interventions versus usual care, Outcome 3: Blood pressure target achievement

Comparison 2: Organisational interventions versus usual care, Outcome 4: Mean total cholesterol

Figuras y tablas -
Analysis 2.4

Comparison 2: Organisational interventions versus usual care, Outcome 4: Mean total cholesterol

Comparison 2: Organisational interventions versus usual care, Outcome 5: Total cholesterol target achievement

Figuras y tablas -
Analysis 2.5

Comparison 2: Organisational interventions versus usual care, Outcome 5: Total cholesterol target achievement

Comparison 2: Organisational interventions versus usual care, Outcome 6: Mean low density lipoprotein

Figuras y tablas -
Analysis 2.6

Comparison 2: Organisational interventions versus usual care, Outcome 6: Mean low density lipoprotein

Comparison 2: Organisational interventions versus usual care, Outcome 7: Low density lipoprotein target achievement

Figuras y tablas -
Analysis 2.7

Comparison 2: Organisational interventions versus usual care, Outcome 7: Low density lipoprotein target achievement

Comparison 2: Organisational interventions versus usual care, Outcome 8: Mean high density lipoprotein

Figuras y tablas -
Analysis 2.8

Comparison 2: Organisational interventions versus usual care, Outcome 8: Mean high density lipoprotein

Comparison 2: Organisational interventions versus usual care, Outcome 9: High density lipoprotein target achievement

Figuras y tablas -
Analysis 2.9

Comparison 2: Organisational interventions versus usual care, Outcome 9: High density lipoprotein target achievement

Comparison 2: Organisational interventions versus usual care, Outcome 10: Mean triglycerides

Figuras y tablas -
Analysis 2.10

Comparison 2: Organisational interventions versus usual care, Outcome 10: Mean triglycerides

Comparison 2: Organisational interventions versus usual care, Outcome 11: Triglyceride target achievement

Figuras y tablas -
Analysis 2.11

Comparison 2: Organisational interventions versus usual care, Outcome 11: Triglyceride target achievement

Comparison 2: Organisational interventions versus usual care, Outcome 12: Mean HbA1C

Figuras y tablas -
Analysis 2.12

Comparison 2: Organisational interventions versus usual care, Outcome 12: Mean HbA1C

Comparison 2: Organisational interventions versus usual care, Outcome 13: HbA1C target achievement

Figuras y tablas -
Analysis 2.13

Comparison 2: Organisational interventions versus usual care, Outcome 13: HbA1C target achievement

Comparison 2: Organisational interventions versus usual care, Outcome 14: Mean BMI

Figuras y tablas -
Analysis 2.14

Comparison 2: Organisational interventions versus usual care, Outcome 14: Mean BMI

Comparison 2: Organisational interventions versus usual care, Outcome 15: BMI target achievement

Figuras y tablas -
Analysis 2.15

Comparison 2: Organisational interventions versus usual care, Outcome 15: BMI target achievement

Comparison 2: Organisational interventions versus usual care, Outcome 16: Mean Framingham cardiovascular risk score

Figuras y tablas -
Analysis 2.16

Comparison 2: Organisational interventions versus usual care, Outcome 16: Mean Framingham cardiovascular risk score

Comparison 2: Organisational interventions versus usual care, Outcome 17: Proportion of participants with secondary stroke or TIA

Figuras y tablas -
Analysis 2.17

Comparison 2: Organisational interventions versus usual care, Outcome 17: Proportion of participants with secondary stroke or TIA

Comparison 2: Organisational interventions versus usual care, Outcome 18: Number of secondary strokes

Figuras y tablas -
Analysis 2.18

Comparison 2: Organisational interventions versus usual care, Outcome 18: Number of secondary strokes

Comparison 2: Organisational interventions versus usual care, Outcome 19: Number of secondary TIAs

Figuras y tablas -
Analysis 2.19

Comparison 2: Organisational interventions versus usual care, Outcome 19: Number of secondary TIAs

Comparison 2: Organisational interventions versus usual care, Outcome 20: Number of secondary TIA or stroke

Figuras y tablas -
Analysis 2.20

Comparison 2: Organisational interventions versus usual care, Outcome 20: Number of secondary TIA or stroke

Comparison 2: Organisational interventions versus usual care, Outcome 21: Proportion of participants with secondary cardiovascular events

Figuras y tablas -
Analysis 2.21

Comparison 2: Organisational interventions versus usual care, Outcome 21: Proportion of participants with secondary cardiovascular events

Comparison 2: Organisational interventions versus usual care, Outcome 22: Number of secondary cardiovascular events

Figuras y tablas -
Analysis 2.22

Comparison 2: Organisational interventions versus usual care, Outcome 22: Number of secondary cardiovascular events

Comparison 2: Organisational interventions versus usual care, Outcome 23: Number of myocardial infarctions

Figuras y tablas -
Analysis 2.23

Comparison 2: Organisational interventions versus usual care, Outcome 23: Number of myocardial infarctions

Comparison 2: Organisational interventions versus usual care, Outcome 24: Number of vascular deaths

Figuras y tablas -
Analysis 2.24

Comparison 2: Organisational interventions versus usual care, Outcome 24: Number of vascular deaths

Summary of findings 1. Educational or behavioural interventions for patients compared to usual care for improving modifiable risk factor control in the secondary prevention of stroke

Educational or behavioural interventions for patients compared to usual care for improving modifiable risk factor control in the secondary prevention of stroke

Patient or population: The trials included a total of 33,840 participants with cerebrovascular disease. The mean or median age of participants ranged from 60 years to 74.3 years. Nine studies included participants with diagnoses of ischaemic stroke; six studies included participants with either ischaemic or haemorrhagic stroke; one focused on lacunar strokes; two did not specify stroke subtype; four included participants with TIA only and 19 trials included a broader range of participants with a diagnosis of either stroke or TIA.

Settings: Primary or secondary care

Intervention: Educational or behavioural interventions for patients

Comparison: Usual care

Outcomes

№ of participants
(studies)
Follow up

Quality of the evidence
(GRADE)

Relative effect
(95% CI)

Anticipated absolute effects* (95% CI)

Risk with usual care

Risk difference with Educational or behavioural interventions for patients

Mean systolic blood pressure

1398
(11 RCTs)

⊕⊕⊕⊝
MODERATE 1

The mean systolic blood pressure was 135.59 mmHg

MD 2.81 mmHg lower
(7.02 lower to 1.39 higher)

Mean diastolic blood pressure

1398
(11 RCTs)

⊕⊕⊕⊝
MODERATE 1

The mean diastolic blood pressure was 78.28 mmHg

MD 0.83 mmHg lower
(2.8 lower to 1.13 higher)

Blood pressure target achievement

266
(3 RCTs)

⊕⊕⊕⊝
MODERATE 1

OR 1.34
(0.70 to 2.59)

Study population

385 per 1000

71 more per 1000
(80 fewer to 234 more)

Low

260 per 1000

60 more per 1000
(63 fewer to 216 more)

High

430 per 1000

73 more per 1000
(84 fewer to 231 more)

Medication adherence

33,762
(13 RCTs)

⊕⊕⊝⊝
LOW 1 2 3

Most studies measuring medication adherence outcomes found no significant differences between the intervention and control groups on any indicator of adherence

Mean low density lipoprotein

495
(4 RCTs)

⊕⊕⊕⊝
MODERATE 4

The mean low density lipoprotein was 2.62 mmol/L

MD 0.13 mmol/L lower
(0.28 lower to 0.02 higher)

Mean HbA1c

70
(1 RCT)

⊕⊕⊝⊝
LOW 4 5

The mean HbA1c was 5.98

MD 0.11 lower
(0.39 lower to 0.17 higher)

Mean BMI

127
(2 RCTs)

⊕⊕⊕⊝
MODERATE 4

The mean BMI was 24.01 kg/m²

MD 0.22 kg/m² higher
(0.85 lower to 1.29 higher)

*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI: Confidence interval; OR: Odds ratio;

GRADE Working Group grades of evidence
High quality: We are very confident that the true effect lies close to that of the estimate of the effect
Moderate quality: We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different
Low quality: Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect
Very low quality: We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect

1 The methods used in these studies were heterogenous which made these difficult to directly correlate

2 Contains at least one study that scores 'high' using the Cochrane risk analysis and thus down graded by one level

3 Results were inconsistent across the studies

4 Secondary outcome

5 One study provided evidence for this outcome

Figuras y tablas -
Summary of findings 1. Educational or behavioural interventions for patients compared to usual care for improving modifiable risk factor control in the secondary prevention of stroke
Summary of findings 2. Organisational interventions compared to usual care for improving modifiable risk factor control in the secondary prevention of stroke

Organisational interventions compared to usual care for improving modifiable risk factor control in the secondary prevention of stroke

Patient or population: The trials included a total of 33,840 participants with cerebrovascular disease. The mean or median age of participants ranged from 60 years to 74.3 years. Nine studies included participants with diagnoses of ischaemic stroke; six studies included participants with either ischaemic or haemorrhagic stroke; one focused on lacunar strokes; two did not specify stroke subtype; four included participants with TIA only and 19 trials included a broader range of participants with a diagnosis of either stroke or TIA.

Settings: Primary or secondary care

Intervention: Organisational derived interventions

Comparison: Usual care

Outcomes

№ of participants
(studies)
Follow up

Quality of the evidence
(GRADE)

Relative effect
(95% CI)

Anticipated absolute effects* (95% CI)

Risk with usual care

Risk difference with Organisational interventions

Mean systolic blood pressure

17,490
(16 RCTs)

⊕⊕⊕⊝
MODERATE2

The mean mean systolic blood pressure was 133.85 mmHg

MD 1.58 mmHg lower
(‐4.66 lower to 1.51 higher)

Mean diastolic blood pressure

17,178
(14 RCTs)

⊕⊕⊕⊝
MODERATE2

The mean mean diastolic blood pressure was 75.12 mmHg

MD 0.91 mmHg lower
(‐2.75 lower to 0.93 higher)

Blood pressure target achievement

23,631
(13 RCTs)

⊕⊕⊕⊝
MODERATE2

OR 1.44
(1.09 to 1.90)

Study population

391 per 1000

89 more per 1000
(21 more to 159 more)

Low

220 per 1000

69 more per 1000
(15 more to 129 more)

High

800 per 1000

52 more per 1000
(13 more to 84 more)

Sensitivity analysis

  1. Repeating analyses excluding unpublished studies: no unpublished results included

  2. Repeating analyses excluding studies at high risk of bias (OR 1.44, 95% CI 1.05 to 1.97, P = 0.02) or unclear risk of bias (OR 1.20, 95% CI 1.11 to 1.29, P < 0.05)

  3. Repeating analyses excluding very large studies to investigate the extent to which they dominated the results (OR 1.31, 95% CI 1.09 to 1.57, P < 0.05)

  4. Repeating analyses using different statistical models (fixed‐effect OR 1.35, 95% CI 1.28 to 1.57, P < 0.05)

Medication adherence

5384
(8 RCTs)

⊕⊕⊝⊝
LOW 1 2 3

Most studies measuring medication adherence outcomes found no significant differences between the intervention and control groups on any indicator of adherence

Mean low density lipoprotein

1008
(5 RCTs)

⊕⊕⊕⊝
MODERATE 4

The mean mean low density lipoprotein was 2.60 mmol/L

MD 0.21 mmol/L lower
(‐0.31 to ‐0.11)

Mean HbA1C

554
(4 RCTs)

⊕⊕⊝⊝
LOW 3 4

The mean mean HbA1c was 5.71

MD 0.2 lower
(‐0.98 to 0.59)

Mean BMI

1089
(5 RCTs)

⊕⊕⊝⊝
LOW 3 4

The mean mean BMI was 27.89 kg/m²

MD 0.47 kg/m² lower
(‐1.24 to 0.30)

*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI: Confidence interval; RR: Risk ratio; OR: Odds ratio;

GRADE Working Group grades of evidence
High quality: We are very confident that the true effect lies close to that of the estimate of the effect
Moderate quality: We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different
Low quality: Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect
Very low quality: We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect

1 One included study did not include an explanation of blinding

2 The methods and outcome measures used in these studies were heterogenous which made these difficult to directly correlate

3 One study deemed high risk when assessed using Cochrane risk of bias tool Contains at least one study thus down graded by one level

4 The methods used in these studies were heterogenous which made these difficult to directly correlate

Figuras y tablas -
Summary of findings 2. Organisational interventions compared to usual care for improving modifiable risk factor control in the secondary prevention of stroke
Table 1. Intervention categories

Study

Educational/behavioural interventions for patients

Educational/behavioural interventions for service providers

Organisational interventions

 

Predominant intervention category

Revision of professional roles

Collaboration between multidisciplinary teams

Integrated care services

Knowledge management systems

Quality management

Financial incentives

Allen 2002

X

X

 

X

X

 

 

 

Organisational

Allen 2009

X

X

 

X

X

 

 

 

Organisational

Boter 2004

X

 

 

 

X

 

 

 

Organisational

Brotons 2011

X

X

 

 

X

 

 

 

Organisational

Damush 2015

X

X

Organisational

Dregan 2014

X

X

Organisational

Ellis 2005

X

 

 

 

X

 

 

 

Organisational

Evans 2010

X

 

X

 

X

 

 

 

Organisational

Flemming 2013

X

X

X

X

X

Organisational

Hanley 2015

X

X

X

Organisational

Hedegaard 2014

X

X

X

Organisational

Hornnes 2011

X

 

 

 

X

 

 

 

Organisational

Nailed Stroke 2010

X

X

X

X

Organisational

Johnston 2010

 

X

 

 

 

 

X

 

Organisational

Jönsson 2014

X

X

X

X

Organisational

Joubert 2009

X

X

 

X

X

X

 

 

Organisational

Kerry 2013

X

X

Organisational

Lowrie 2010

X

X

Organisational

Mant 2016

X

X

Organisational

Markle‐Reid 2011

X

X

X

X

Organisational

McAlister 2014

X

X

X

X

X

Organisational

McManus 2014

X

X

X

Organisational

Pergola 2014

X

Organisational

Ranta 2015

X

X

Organisational

Wang 2005

X

 

 

 

X

 

 

 

Organisational

Welin 2010

X

 

 

 

X

 

 

 

Organisational

Adie 2010

X

Educational/behavioural intervention for patients

MIST 2014

X

Educational/behavioural intervention for patients

Boysen 2009

X

 

 

 

 

 

 

 

Educational/behavioural intervention for patients

Chanruengvanich 2006

X

 

 

 

 

 

 

 

Educational/behavioural intervention for patients

Chiu 2008

X

 

 

 

 

 

 

 

Educational/behavioural intervention for patients

Eames 2013

X

 

 

 

 

 

 

 

Educational/behavioural intervention for patients

Kim 2013

X

Educational/behavioural intervention for patients

Kono 2013

X

Educational/behavioural intervention for patients

Kronish 2014

X

Educational/behavioural intervention for patients

Lowe 2007

X

 

 

 

 

 

 

 

Educational/behavioural intervention for patients

Maasland 2007

X

 

 

 

 

 

 

 

Educational/behavioural intervention for patients

MacKenzie 2013

X

X

Educational/behavioural intervention for patients

O'Carroll 2011

X

Educational/behavioural intervention for patients

Peng 2014

X

Educational/behavioural intervention for patients

Slark 2013

X

Educational/behavioural intervention for patients

Wan 2016

X

X

Educational/behavioural intervention for patients

Figuras y tablas -
Table 1. Intervention categories
Comparison 1. Educational or behavioural interventions for patients versus usual care

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1.1 Mean systolic blood pressure Show forest plot

11

1398

Mean Difference (IV, Random, 95% CI)

‐2.81 [‐7.02, 1.39]

1.2 Mean diastolic blood pressure Show forest plot

11

1398

Mean Difference (IV, Random, 95% CI)

‐0.83 [‐2.80, 1.13]

1.3 Blood pressure target achievement Show forest plot

3

266

Odds Ratio (M‐H, Random, 95% CI)

0.74 [0.39, 1.44]

1.4 Mean total cholesterol Show forest plot

7

721

Mean Difference (IV, Random, 95% CI)

0.10 [‐0.28, 0.47]

1.5 Total cholesterol target achievement Show forest plot

1

56

Odds Ratio (M‐H, Random, 95% CI)

1.78 [0.60, 5.30]

1.6 Mean low density lipoprotein Show forest plot

4

495

Mean Difference (IV, Random, 95% CI)

‐0.13 [‐0.28, 0.02]

1.7 Mean high density lipoprotein Show forest plot

3

452

Mean Difference (IV, Random, 95% CI)

‐0.03 [‐0.11, 0.05]

1.8 Mean triglycerides Show forest plot

3

182

Mean Difference (IV, Random, 95% CI)

‐0.01 [‐0.31, 0.30]

1.9 Mean HbA1c Show forest plot

1

70

Mean Difference (IV, Random, 95% CI)

‐0.11 [‐0.39, 0.17]

1.10 HbA1C target achievement Show forest plot

1

67

Odds Ratio (M‐H, Random, 95% CI)

1.53 [0.57, 4.08]

1.11 Mean BMI Show forest plot

2

127

Mean Difference (IV, Random, 95% CI)

0.22 [‐0.85, 1.29]

1.12 Proporation of participants with secondary stroke Show forest plot

4

4333

Odds Ratio (M‐H, Random, 95% CI)

0.82 [0.37, 1.84]

1.13 Number of secondary TIAs Show forest plot

2

4207

Odds Ratio (M‐H, Random, 95% CI)

1.09 [0.52, 2.30]

1.14 Number of myocardial infarctions Show forest plot

3

4277

Odds Ratio (M‐H, Random, 95% CI)

0.53 [0.17, 1.65]

1.15 Number of cardiovascular deaths Show forest plot

1

386

Odds Ratio (M‐H, Random, 95% CI)

1.34 [0.30, 6.07]

Figuras y tablas -
Comparison 1. Educational or behavioural interventions for patients versus usual care
Comparison 2. Organisational interventions versus usual care

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

2.1 Mean systolic blood pressure Show forest plot

16

17490

Mean Difference (IV, Random, 95% CI)

‐1.58 [‐4.66, 1.51]

2.2 Mean diastolic blood pressure Show forest plot

14

17178

Mean Difference (IV, Random, 95% CI)

‐0.91 [‐2.75, 0.93]

2.3 Blood pressure target achievement Show forest plot

13

23631

Odds Ratio (M‐H, Random, 95% CI)

0.70 [0.53, 0.92]

2.4 Mean total cholesterol Show forest plot

7

11955

Mean Difference (IV, Random, 95% CI)

‐0.00 [‐0.04, 0.03]

2.5 Total cholesterol target achievement Show forest plot

6

12539

Odds Ratio (M‐H, Random, 95% CI)

0.78 [0.53, 1.17]

2.6 Mean low density lipoprotein Show forest plot

5

1154

Mean Difference (IV, Random, 95% CI)

‐0.19 [‐0.30, ‐0.09]

2.7 Low density lipoprotein target achievement Show forest plot

5

1790

Odds Ratio (M‐H, Random, 95% CI)

0.73 [0.47, 1.13]

2.8 Mean high density lipoprotein Show forest plot

4

522

Mean Difference (IV, Random, 95% CI)

‐0.02 [‐0.09, 0.04]

2.9 High density lipoprotein target achievement Show forest plot

1

36

Odds Ratio (M‐H, Random, 95% CI)

0.79 [0.20, 3.07]

2.10 Mean triglycerides Show forest plot

3

485

Mean Difference (IV, Random, 95% CI)

‐0.08 [‐0.21, 0.04]

2.11 Triglyceride target achievement Show forest plot

1

36

Odds Ratio (M‐H, Random, 95% CI)

4.00 [0.85, 18.84]

2.12 Mean HbA1C Show forest plot

4

554

Mean Difference (IV, Random, 95% CI)

‐0.20 [‐0.98, 0.59]

2.13 HbA1C target achievement Show forest plot

3

553

Odds Ratio (M‐H, Random, 95% CI)

0.25 [0.02, 3.33]

2.14 Mean BMI Show forest plot

5

1089

Mean Difference (IV, Random, 95% CI)

‐0.47 [‐1.24, 0.30]

2.15 BMI target achievement Show forest plot

2

234

Odds Ratio (M‐H, Random, 95% CI)

0.58 [0.31, 1.08]

2.16 Mean Framingham cardiovascular risk score Show forest plot

1

36

Mean Difference (IV, Random, 95% CI)

‐6.50 [‐10.22, ‐2.78]

2.17 Proportion of participants with secondary stroke or TIA Show forest plot

4

791

Odds Ratio (M‐H, Random, 95% CI)

0.66 [0.23, 1.86]

2.18 Number of secondary strokes Show forest plot

4

789

Odds Ratio (M‐H, Random, 95% CI)

1.00 [0.54, 1.87]

2.19 Number of secondary TIAs Show forest plot

1

102

Odds Ratio (M‐H, Random, 95% CI)

3.80 [1.57, 9.24]

2.20 Number of secondary TIA or stroke Show forest plot

1

291

Odds Ratio (M‐H, Random, 95% CI)

0.26 [0.08, 0.85]

2.21 Proportion of participants with secondary cardiovascular events Show forest plot

1

324

Odds Ratio (M‐H, Random, 95% CI)

1.48 [0.79, 2.77]

2.22 Number of secondary cardiovascular events Show forest plot

2

381

Odds Ratio (M‐H, Random, 95% CI)

0.73 [0.25, 2.15]

2.23 Number of myocardial infarctions Show forest plot

1

314

Odds Ratio (M‐H, Random, 95% CI)

1.00 [0.14, 7.19]

2.24 Number of vascular deaths Show forest plot

2

605

Odds Ratio (M‐H, Random, 95% CI)

0.38 [0.15, 0.97]

Figuras y tablas -
Comparison 2. Organisational interventions versus usual care